Correlation Between VistaGen Therapeutics and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and ANI Pharmaceuticals, you can compare the effects of market volatilities on VistaGen Therapeutics and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and ANI Pharmaceuticals.
Diversification Opportunities for VistaGen Therapeutics and ANI Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between VistaGen and ANI is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and ANI Pharmaceuticals
Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 13.34 times more return on investment than ANI Pharmaceuticals. However, VistaGen Therapeutics is 13.34 times more volatile than ANI Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest 394.00 in VistaGen Therapeutics on August 27, 2024 and sell it today you would lose (136.00) from holding VistaGen Therapeutics or give up 34.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. ANI Pharmaceuticals
Performance |
| Timeline |
| VistaGen Therapeutics |
| ANI Pharmaceuticals |
VistaGen Therapeutics and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and ANI Pharmaceuticals
The main advantage of trading using opposite VistaGen Therapeutics and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Histogen | VistaGen Therapeutics vs. Entera Bio |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |